Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncogene Proteins, Fusion | 6 | 2022 | 236 | 2.460 |
Why?
|
| RNA | 8 | 2022 | 606 | 2.290 |
Why?
|
| Gene Fusion | 4 | 2022 | 61 | 1.430 |
Why?
|
| 5' Untranslated Regions | 1 | 2024 | 61 | 0.840 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 39 | 0.740 |
Why?
|
| RNA, Catalytic | 4 | 2007 | 15 | 0.730 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 146 | 0.730 |
Why?
|
| Endometrial Neoplasms | 1 | 2021 | 116 | 0.670 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 2669 | 0.670 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 468 | 0.660 |
Why?
|
| Microtubule Proteins | 1 | 2018 | 29 | 0.600 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 718 | 0.540 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 2137 | 0.510 |
Why?
|
| RNA, Messenger | 6 | 2020 | 2911 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 962 | 0.460 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 58 | 0.450 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 46 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2014 | 6 | 0.440 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 709 | 0.440 |
Why?
|
| N-Terminal Acetyltransferase C | 1 | 2013 | 2 | 0.430 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2175 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 512 | 0.380 |
Why?
|
| Transcription Factors | 1 | 2021 | 2730 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 593 | 0.350 |
Why?
|
| Transfection | 3 | 2021 | 1096 | 0.350 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2022 | 42 | 0.340 |
Why?
|
| Alternative Splicing | 3 | 2024 | 378 | 0.320 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 396 | 0.300 |
Why?
|
| Cell Line | 7 | 2020 | 2860 | 0.300 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2009 | 82 | 0.300 |
Why?
|
| Oncogene Fusion | 2 | 2022 | 26 | 0.290 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1721 | 0.290 |
Why?
|
| Biological Assay | 1 | 2009 | 111 | 0.290 |
Why?
|
| Genetic Engineering | 2 | 2007 | 164 | 0.270 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 138 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 872 | 0.270 |
Why?
|
| Eye Proteins | 2 | 2018 | 234 | 0.250 |
Why?
|
| Base Sequence | 5 | 2015 | 3178 | 0.250 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1613 | 0.240 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1834 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 261 | 0.230 |
Why?
|
| Poly A | 1 | 2024 | 60 | 0.220 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 307 | 0.210 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3796 | 0.210 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 609 | 0.200 |
Why?
|
| Transgenes | 1 | 2024 | 346 | 0.200 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 363 | 0.190 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2001 | 152 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1626 | 0.190 |
Why?
|
| Mammals | 1 | 2022 | 280 | 0.170 |
Why?
|
| Endoribonucleases | 1 | 2001 | 85 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2021 | 246 | 0.170 |
Why?
|
| Stromal Cells | 1 | 2021 | 313 | 0.170 |
Why?
|
| N-Methylaspartate | 2 | 2001 | 28 | 0.160 |
Why?
|
| Chromosome Breakpoints | 1 | 2020 | 83 | 0.160 |
Why?
|
| Humans | 17 | 2024 | 134084 | 0.160 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3979 | 0.160 |
Why?
|
| DNA, Single-Stranded | 1 | 1999 | 76 | 0.160 |
Why?
|
| Estrogens | 1 | 2021 | 525 | 0.150 |
Why?
|
| Progesterone | 1 | 2021 | 635 | 0.150 |
Why?
|
| Endometrium | 1 | 2021 | 289 | 0.150 |
Why?
|
| Computational Biology | 2 | 2016 | 888 | 0.150 |
Why?
|
| SELEX Aptamer Technique | 2 | 2016 | 6 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 30 | 0.150 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2018 | 38 | 0.150 |
Why?
|
| Huntington Disease | 1 | 1999 | 146 | 0.150 |
Why?
|
| Animals | 9 | 2024 | 36545 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 793 | 0.140 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 204 | 0.140 |
Why?
|
| Genome, Human | 2 | 2021 | 1345 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 282 | 0.140 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 1126 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 1923 | 0.130 |
Why?
|
| Polyps | 1 | 2017 | 44 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 1627 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2009 | 398 | 0.120 |
Why?
|
| Toyocamycin | 2 | 2006 | 2 | 0.120 |
Why?
|
| Superior Colliculi | 1 | 1995 | 15 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 137 | 0.110 |
Why?
|
| Adenosine | 2 | 2006 | 140 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 428 | 0.110 |
Why?
|
| Mice | 4 | 2024 | 19047 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2013 | 485 | 0.110 |
Why?
|
| Chimerism | 1 | 2013 | 29 | 0.110 |
Why?
|
| Retinal Ganglion Cells | 1 | 1995 | 119 | 0.110 |
Why?
|
| Neurons | 2 | 2020 | 2049 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2015 | 650 | 0.110 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 78 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 331 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2015 | 489 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2013 | 5217 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2020 | 951 | 0.100 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 91 | 0.100 |
Why?
|
| Axons | 1 | 1995 | 395 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 296 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 678 | 0.090 |
Why?
|
| Clone Cells | 2 | 2009 | 180 | 0.090 |
Why?
|
| Synapses | 1 | 1995 | 469 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1712 | 0.090 |
Why?
|
| Proteins | 1 | 2016 | 1099 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 652 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2794 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 399 | 0.080 |
Why?
|
| Prostatectomy | 1 | 2011 | 357 | 0.080 |
Why?
|
| Female | 4 | 2021 | 71893 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 797 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2004 | 970 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2011 | 504 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 88 | 0.070 |
Why?
|
| Schistosoma mansoni | 1 | 2007 | 24 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1787 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 505 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 1137 | 0.070 |
Why?
|
| Tubercidin | 1 | 2006 | 2 | 0.060 |
Why?
|
| Acridine Orange | 1 | 2006 | 3 | 0.060 |
Why?
|
| Ethidium | 1 | 2006 | 6 | 0.060 |
Why?
|
| Cytidine | 1 | 2006 | 10 | 0.060 |
Why?
|
| Uridine | 1 | 2006 | 37 | 0.060 |
Why?
|
| Guanine | 1 | 2006 | 63 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 151 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2006 | 141 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 158 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 135 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 320 | 0.060 |
Why?
|
| Base Pairing | 1 | 2004 | 42 | 0.060 |
Why?
|
| Catalysis | 1 | 2004 | 138 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2004 | 93 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2006 | 780 | 0.060 |
Why?
|
| Cricetinae | 1 | 2004 | 398 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 5086 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 443 | 0.050 |
Why?
|
| Mutation | 2 | 2014 | 6316 | 0.050 |
Why?
|
| Exons | 2 | 2010 | 837 | 0.050 |
Why?
|
| Gene Expression | 2 | 2018 | 1621 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 3043 | 0.050 |
Why?
|
| Ribonuclease T1 | 1 | 2001 | 2 | 0.050 |
Why?
|
| Ribonuclease P | 1 | 2001 | 10 | 0.040 |
Why?
|
| RNA, Small Untranslated | 1 | 2001 | 21 | 0.040 |
Why?
|
| RNA Editing | 1 | 2001 | 36 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2001 | 139 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2001 | 107 | 0.040 |
Why?
|
| DNA, Catalytic | 1 | 1999 | 4 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1999 | 110 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 171 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 466 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 152 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 482 | 0.030 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 58 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2018 | 264 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 196 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 63 | 0.030 |
Why?
|
| Astrocytes | 1 | 2020 | 273 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 1433 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 249 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2018 | 303 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 3890 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 120 | 0.030 |
Why?
|
| Male | 2 | 2013 | 66093 | 0.030 |
Why?
|
| Metamorphosis, Biological | 1 | 1995 | 7 | 0.030 |
Why?
|
| Horseradish Peroxidase | 1 | 1995 | 14 | 0.030 |
Why?
|
| Rana pipiens | 1 | 1995 | 38 | 0.030 |
Why?
|
| Synaptic Membranes | 1 | 1995 | 23 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 51 | 0.030 |
Why?
|
| Axonal Transport | 1 | 1995 | 28 | 0.030 |
Why?
|
| Aged | 1 | 2013 | 21772 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2001 | 3187 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 367 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 1995 | 151 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 746 | 0.030 |
Why?
|
| Spinal Cord | 1 | 1995 | 276 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 1012 | 0.030 |
Why?
|
| Middle Aged | 1 | 2013 | 29394 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 787 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1071 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2013 | 789 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2562 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 3223 | 0.020 |
Why?
|
| Allosteric Site | 1 | 2007 | 12 | 0.020 |
Why?
|
| Theophylline | 1 | 2007 | 30 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 16 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 64 | 0.020 |
Why?
|
| Caffeine | 1 | 2007 | 70 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2007 | 198 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 1357 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 1909 | 0.010 |
Why?
|
| Sequence Analysis, RNA | 1 | 2007 | 426 | 0.010 |
Why?
|
| Neoplasms | 1 | 2013 | 3037 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 73 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1995 | 136 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 1310 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1995 | 1044 | 0.010 |
Why?
|